How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Chronic Disease Management App Market
- By Disease Focus: Diabetes Management, Cardiovascular Disease Management, Chronic Respiratory Disease Management, Arthritis Management, Chronic Kidney Disease Management
- By Platform Type: Mobile Applications, Web-Based Applications, Wearable Device Integrated Apps, Cloud-Based Platforms
- By End User: Patients, Healthcare Providers, Caregivers, Pharmaceutical Companies
- By Functionality: Medication Management, Remote Patient Monitoring, Lifestyle and Diet Tracking, Symptom Tracking and Reporting, Teleconsultation Integration
- By Deployment Mode: Standalone Applications, Integrated with Electronic Health Records (EHR) Systems, Enterprise Solutions for Healthcare Organizations
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Diabetes Management leads By Disease Focus at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Chronic Disease Management App Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cerner Corporation (now part of Oracle)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Allscripts Healthcare Solutions
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →IBM Watson Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Epic Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Livongo Health (now part of Teladoc Health)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Omada Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Propeller Health (ResMed)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Health Catalyst
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →WellDoc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →MySugr (a Roche company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Dexcom
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Glooko
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Teladoc Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Diabetes Management47.5
- Cardiovascular Disease Management10.6
- Chronic Respiratory Disease Management9.7
- Arthritis Management17.1
- Chronic Kidney Disease Management15.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips Healthcare18.6
- Cerner Corporation (now part of Oracle)13.0
- Allscripts Healthcare Solutions7.7
- Medtronic6.5
- IBM Watson Health15.0
- Epic Systems Corporation11.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe23.5
- Asia Pacific20.8
- Latin America12.5
- Middle East and Africa9.5
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips Healthcare | 82 | 86 | 92 | 85 | 87 | 95 | 88 |
| Cerner Corporation (now part of Oracle) | 74 | 85 | 83 | 85 | 88 | 92 | 85 |
| Allscripts Healthcare Solutions | 65 | 69 | 72 | 74 | 72 | 83 | 73 |
| Medtronic | 62 | 70 | 58 | 65 | 63 | 75 | 66 |
| IBM Watson Health | 64 | 52 | 63 | 59 | 70 | 58 | 61 |
| Epic Systems Corporation | 47 | 71 | 52 | 46 | 52 | 55 | 54 |
| Livongo Health (now part of Teladoc Health) | 64 | 50 | 60 | 41 | 53 | 65 | 56 |
| Omada Health | 56 | 59 | 59 | 38 | 58 | 42 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips Healthcare
- Cerner Corporation (now part of Oracle)
- Allscripts Healthcare Solutions
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips Healthcare | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cerner Corporation (now part of Oracle) | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Allscripts Healthcare Solutions | − | ◐ | ◐ | ✓ | ◐ | ◐ |
| Medtronic | ◐ | − | ◐ | − | ◐ | ◐ |
| IBM Watson Health | − | − | − | − | ✓ | − |
| Epic Systems Corporation | − | − | ◐ | − | − | − |
| Livongo Health (now part of Teladoc Health) | ◐ | − | ◐ | − | ◐ | ◐ |
| Omada Health | ◐ | ◐ | ◐ | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger1
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche3
Specialists in a single segment or region.
Go-to-market strategy
Land Disease Focus in North America, then scale across Chronic Disease Management App Market — a $322M beachhead inside a $5.33B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Diabetes Management
Best fit — highest urgency & budget in Disease Focus.
Cardiovascular Disease Management
Strong fit — clear ROI and a fast path to value.
Chronic Respiratory Disease Management
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Disease Focus in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Platform Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Disease Focus leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Chronic Disease Management App Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Chronic Disease Management App Market is a high-growth opportunity — $1.20B by 2033, compounding at 11.6%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.6% CAGR
Demand compounds through 2033, outpacing GDP across Disease Focus.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Disease Focus moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Platform Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Chronic Disease Management App Market — a $1.40B market by 2033. Plan: grow share from 10.8% to 17.7%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.8% | 17.7% | Ahead |
| Revenue | $149M | $248M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 28.7% | 40.2% | On track |
| Customer retention | 88.3% | 92.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Disease Focus
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Platform Type capability
A defensible second engine — invest in Platform Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Disease Focus share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Platform Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $26M capacity & capability investment
- Greenlight bolt-on M&A in Platform Type
- Authorise North America expansion plan
- Fund R&D program for Disease Focus leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentAhead
Sales deck · value proposition
Win the Chronic Disease Management App Market conversation — a $4.94B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Disease Focus
Goal Grow share in Disease Focus
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Chronic Disease Management App Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Chronic Disease Management App Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Chronic Disease Care Management Software Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportChronic Cough Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportChronic Cerebellar Stimulator Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportChronic Brain Damage Treatment Market
Market size, share, segmentation and regional forecast.
$641M market · 2025 base year
View reportChronic Bacterial Prostatitis Drugs Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportChronic Back Pain Treatment Market
Market size, share, segmentation and regional forecast.
$346M market · 2025 base year
View reportChromosome Microarray Market
Market size, share, segmentation and regional forecast.
$794M market · 2025 base year
View reportChromosome Harvesting System Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportChromosome Harvesters Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportChromosomal Microarray Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportChromosomal Microarray (CMA) Testing Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportChromosomal Microarray (CMA) Familial Testing Market
Market size, share, segmentation and regional forecast.
$830M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy